featured
Combination Nivolumab and Ipilimumab or Nivolumab Alone in Melanoma Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Combination Nivolumab and Ipilimumab or Nivolumab Alone in Melanoma Brain Metastases: A Multicentre Randomised Phase 2 Study
Lancet Oncol 2018 Mar 27;[EPub Ahead of Print], GV Long, V Atkinson, S Lo, S Sandhu, AD Guminski, MP Brown, JS Wilmott, J Edwards, M Gonzalez, RA Scolyer, AM Menzies, GA McArthurFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.